PM

Prosight Management Portfolio holdings

AUM $410M
This Quarter Return
+7.24%
1 Year Return
-14.96%
3 Year Return
+21.81%
5 Year Return
+1.17%
10 Year Return
AUM
$176M
AUM Growth
+$176M
Cap. Flow
+$30.4M
Cap. Flow %
17.23%
Top 10 Hldgs %
61.25%
Holding
42
New
11
Increased
10
Reduced
10
Closed
10
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
CDTX icon
26
Cidara Therapeutics
CDTX
$1.61B
$1.43M 0.8%
324,902
-833,798
-72% -$3.67M
NVLN
27
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
$1.31M 0.73%
444,068
+249,405
+128% +$738K
KZR icon
28
Kezar Life Sciences
KZR
$28.5M
$1.12M 0.62%
52,331
+10,640
+26% +$228K
TPST icon
29
Tempest Therapeutics
TPST
$46.6M
$1.12M 0.62%
+1,529,700
New +$1.12M
MGTX icon
30
MeiraGTx Holdings
MGTX
$590M
$527K 0.29%
+38,746
New +$527K
NGNE icon
31
Neurogene
NGNE
$284M
$166K 0.09%
56,650
-344,250
-86% -$1.01M
ATHN
32
DELISTED
Athenahealth, Inc.
ATHN
-41,193
Closed -$6.56M
CIVI
33
DELISTED
Civitas Solutions, Inc.
CIVI
-34,649
Closed -$568K
AKAO
34
DELISTED
Achaogen, Inc.
AKAO
-375,000
Closed -$3.25M
AVEO
35
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
-149,073
Closed -$337K
NBRV
36
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
-421,414
Closed -$1.47M
PRTK
37
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
-144,752
Closed -$1.48M
VTRS icon
38
Viatris
VTRS
$12.3B
-80,800
Closed -$2.92M
TVTX icon
39
Travere Therapeutics
TVTX
$1.75B
0
SBRA icon
40
Sabra Healthcare REIT
SBRA
$4.56B
-98,906
Closed -$2.15M
CLLS
41
Cellectis
CLLS
$260M
-19,388
Closed -$548K
ESPR icon
42
Esperion Therapeutics
ESPR
$490M
-48,800
Closed -$1.91M